TNF and hepatocellular carcinoma: Hence, the plasma levels of pro-inflammatory cytokines, such as tumor necrosis factor-α and human interferon-γ, increase (0–4 weeks of protocol) followed by a marked decrease (4–8 weeks of protocol), mimicking the HCC survival behavior in HCC patients [24].